PAMP
REVB icon

Polar Asset Management Partners’s Revelation Biosciences REVB Stock Holding History

Polar Asset Management Partners’s Portfolio REVB Stock Details REVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2
Closed -$4.02M – 1374
2021
Q2 		$4.02M Hold
2
– – 0.04% 426
2021
Q1 		$4M Hold
2
– – 0.04% 386
2020
Q4 		$3.52M Buy
+2
New +$4.03M 0.04% 309

Other funds holding REVB

KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Polar Asset Management Partners's REVB Position: Q3 2021 in Review

Polar Asset Management Partners sold out of Revelation Biosciences (REVB) in Q3 2021, closing a stake of 2 shares — an estimated $4.02M sold.

Polar Asset Management Partners first reported a position in REVB in Q4 2020 and held it in 3 quarters. The position peaked at $4.02M in Q2 2021. 14 funds tracked by Wall St. Rank hold REVB as of Q3 2021.

  • Polar Asset Management Partners reported no remaining Revelation Biosciences position as of Q3 2021 after selling out during the quarter.
  • Polar Asset Management Partners sold 2 Revelation Biosciences shares in Q3 2021, an estimated $4.02M.
  • Polar Asset Management Partners first reported a position in Revelation Biosciences in Q4 2020 and held it in 3 quarters.
  • Polar Asset Management Partners's Revelation Biosciences position peaked at $4.02M in Q2 2021.
  • 14 funds tracked by Wall St. Rank held Revelation Biosciences as of Q3 2021.

Based on Polar Asset Management Partners's 13F filing for Q3 2021, filed 15 Nov 2021.